Maximus, Inc. (NYSE:MMS) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Monday, July 24th.
Other analysts have also issued reports about the stock. ValuEngine lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. KeyCorp restated a “sector weight” rating on shares of Maximus in a report on Thursday, May 25th. Jefferies Group LLC downgraded shares of Maximus from a “buy” rating to a “hold” rating and boosted their target price for the stock from $63.00 to $64.00 in a report on Friday, May 5th. Canaccord Genuity restated a “buy” rating and set a $62.00 price target on shares of Maximus in a research note on Friday, April 7th. Finally, Zacks Investment Research lowered Maximus from a “hold” rating to a “sell” rating in a research note on Tuesday, July 18th. One equities research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. Maximus has a consensus rating of “Hold” and a consensus price target of $62.17.
Maximus (NYSE:MMS) opened at 59.30 on Monday. The stock has a 50 day moving average of $60.78 and a 200-day moving average of $61.00. Maximus has a 1-year low of $43.69 and a 1-year high of $64.97. The company has a market cap of $3.85 billion, a PE ratio of 19.01 and a beta of 1.39.
Maximus (NYSE:MMS) last posted its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The firm had revenue of $600.40 million during the quarter, compared to analyst estimates of $614.12 million. During the same period last year, the firm posted $0.79 earnings per share. Maximus’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, equities research analysts predict that Maximus will post $3.12 earnings per share for the current year.
In related news, CEO Richard A. Montoni sold 29,203 shares of the firm’s stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the transaction, the chief executive officer now directly owns 549,215 shares in the company, valued at approximately $33,161,601.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Bruce Caswell sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $62.76, for a total value of $502,080.00. Following the transaction, the president now owns 35,904 shares of the company’s stock, valued at $2,253,335.04. The disclosure for this sale can be found here. Over the last three months, insiders sold 154,342 shares of company stock valued at $9,516,217. 3.10% of the stock is owned by corporate insiders.
Large investors have recently bought and sold shares of the stock. Neuburgh Advisers LLC raised its stake in Maximus by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock worth $105,000 after buying an additional 32 shares in the last quarter. Acrospire Investment Management LLC raised its position in Maximus by 183.3% in the first quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $106,000 after buying an additional 1,100 shares during the period. Glen Harbor Capital Management LLC raised its position in Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock valued at $145,000 after buying an additional 44 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Maximus by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock valued at $148,000 after buying an additional 220 shares during the period. Finally, First Bank & Trust raised its position in Maximus by 4.2% in the second quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock valued at $157,000 after buying an additional 101 shares during the period. 97.20% of the stock is currently owned by institutional investors.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.